In a recent hearing on the reauthorization of PDUFA (Prescription Drug User Fee Act), concerns were raised about the FDA’s decision to revoke the approval of Avastin for use in the treatment of advanced breast cancer. Several congressmen gave heartfelt anecdotes of relatives or friends whose lives were improved or lengthened through the use of … Continue reading →